Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 288-295

  Vaughan, Christopher W ^a   Connor, Mark ^a   Bagley, Elena E ^a   Christie, Macdonald J ^a,b  

^a University of Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; N (4 HYDROXYPHENYL)ARACHIDONYLETHANOLAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; KINETICS; MEMBRANE CONDUCTANCE; NERVE CELL; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CALCIUM; CANNABINOIDS; MORPHOLINES; NAPHTHALENES; NEURONS; PERIAQUEDUCTAL GRAY; PIPERIDINES; POTASSIUM; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; RECEPTORS, GLUTAMATE; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION;

EID: 0033952656     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG and Makriyannis A (1994) (R)-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37:1889-1893.
2. Adams IB, Compton DR and Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284:1209-1217.
3. Bandler R and Shipley MT (1994) Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression? Trends Neurosci 17:379-389.
4. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A and Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (Wash DC) 277:1094-1097.
5. Chan PK, Chan SC and Yung WH (1998) Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9:671-675.
6. Chieng B and Christie MJ (1994) Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol 113:121-128.
7. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol (Lond) 509:47-58.
8. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ and Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1:121-134.
9. del Castillo J and Katz B (1954) Statistical factors involved in neuromuscular facilitation and depression. J Physiol (Lond) 124:574-585.
10. Deutsch DG and Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796.
11. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
12. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
13. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC and Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond) 372:686-691.
14. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
15. Fields HL, Heinricher MM and Mason P (1991) Neurotransmitters in nociceptive modulatory circuits. Anna Rev Neurosci 14:219-245.
16. Henry DJ and Chavkin C (1990) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94.
17. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR and Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
18. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
19. Levenes C, Daniel H, Soubrie P and Crepel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol (Lond) 510:867-879.
20. Lichtman AH, Cook SA and Martin BR (1996) Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 276:585-593.
21. Mackie K, Lai Y, Westenbroek R and Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
22. Martin WJ, Tsou K and Walker JM (1998) Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci Lett 242:33-36.
23. Matsuda LA, Bonner TI and Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550.
24. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
25. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR and Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
26. Meng ID, Manning BH, Martin WJ and Fields HL (1998) An analgesia circuit activated by cannabinoids. Nature (Lond) 395:381-383.
27. Osborne PB, Vaughan CW, Wilson HI and Christie MJ (1996) Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (Lond) 490:383-389.
28. Pan ZZ, Williams JT and Osborne PB (1990) Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol (Lond) 427: 519-532.
29. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere JC and Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
30. Shen M, Piser TM, Seybold VS and Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334.
31. Smith FL, Cichewicz D, Martin ZL and Welch SP (1998) The enhancement of morphine antinociception in mice by Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 60:559-566.
32. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam H and Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227.
33. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A and Waku K (1995) 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
34. Szabo B, Dorner L, Pfreundtner C, Norenberg W and Starke K (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85:395-403.
35. Tsou K, Brown S, Sanudo-Pena MC, Mackie K and Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411.
36. Twitchell W, Brown S and Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78: 43-50.
37. Vaughan CW and Christie MJ (1997) Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (Lond) 498:463-472.
38. Vaughan CW, Ingram SL, Connor MA and Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature (Lond) 390:611-614.
39. Vaughan CW, McGregor IS and Christie MJ (1999) Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol 127:935-940.
40. Walker JM, Huang SM, Strangman NM, Tsou K and Sanudo-Pena MC (1999) Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci USA 96:12198-12203.